Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis [synopsis].
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Mosaic Subventricular Origins of Forebrain Oligodendrogenesis.
Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up.
Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis.
Polymorphisms in CD28, CTLA-4, CD80 and CD86 genes may influence the risk of multiple sclerosis and its age of onset.
The Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells.
Systematic network lesioning reveals the core white matter scaffold of the human brain.
Determinants of disability in multiple sclerosis: an immunological and MRI study.
A case of demyelinating polyneuropathy associated with anti-myelin-associated glycoprotein antibodies with progressive quadriparesis and respiratory failure.
Addressing the regulatory and scientific challenges in multiple sclerosis - a statement from the EU regulators.
[Clinical outcome of the hyperacute form of acute disseminated encephalomyelitis.]
Medical management of fecal incontinence in challenging populations: a review.
Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects.
The influence of vitamin D on postpartum relapse and quality of life in pregnant multiple sclerosis patients.
Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating fingolimod in patients with relapsing-remitting multiple sclerosis.
Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis.
Tumefactive multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience.
Nongenomic actions of neurosteroid pregnenolone and its metabolites.
Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Brain tissue segmentation using fuzzy clustering techniques.
Pages
« first
‹ previous
…
619
620
621
622
623
624
625
626
627
…
next ›
last »